---
figid: PMC3077922__nihms243209f3
figtitle: Gene expression changes in response to zebularine therapy in vivo
organisms:
- Mus musculus
- Rattus norvegicus
- Diaporthe sclerotioides
- Bikinia letestui
- Homo sapiens
- Canis lupus familiaris
pmcid: PMC3077922
filename: nihms243209f3.jpg
figlink: /pmc/articles/PMC3077922/figure/F3/
number: F3
caption: Gene expression changes in response to zebularine therapy in vivo. (A) Hierarchical
  cluster analysis of liver tumors derived from the zebularine sensitive Huh7luc+-xenografts
  identifies a list of 484 differentially expressed genes by Bootstrap-t (P≤.01, 5,000
  repetitions). Control tumors, raloxifene alone (n=6), and the treatment group zebularine
  and raloxifene (n=7). (B, C) Ingenuity Pathway Analysis shows zebularine and raloxifene
  treatment caused a preferential deregulation of genes controlled by the oncogene
  MYC (B) and up-regulation of initiator caspases (e.g. CASP2 and CASP9) (C).
papertitle: An integrated genomic and pharmacoepigenomic approach predicts therapeutic
  response of zebularine in human liver cancer.
reftext: Jesper B. Andersen, et al. Sci Transl Med. ;2(54):54ra77-54ra77.
year: ''
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.5134676
figid_alias: PMC3077922__F3
figtype: Figure
organisms_ner:
- Homo sapiens
- Mus musculus
- Canis lupus familiaris
- Rattus norvegicus
redirect_from: /figures/PMC3077922__F3
ndex: 1148398c-df38-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3077922__nihms243209f3.html
  '@type': Dataset
  description: Gene expression changes in response to zebularine therapy in vivo.
    (A) Hierarchical cluster analysis of liver tumors derived from the zebularine
    sensitive Huh7luc+-xenografts identifies a list of 484 differentially expressed
    genes by Bootstrap-t (P≤.01, 5,000 repetitions). Control tumors, raloxifene alone
    (n=6), and the treatment group zebularine and raloxifene (n=7). (B, C) Ingenuity
    Pathway Analysis shows zebularine and raloxifene treatment caused a preferential
    deregulation of genes controlled by the oncogene MYC (B) and up-regulation of
    initiator caspases (e.g. CASP2 and CASP9) (C).
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - TMEM126A
  - SIN3B
  - LSM3
  - XRN2
  - LSM1
  - CTNNA1
  - TYMS
  - CAST
  - POLR1G
  - ERC2
  - FANCI
  - UXT
  - TOP1
  - NCBP1
  - OMA1
  - HNRNPH1
  - ANXA4
  - CASP1
  - CASP2
  - CASP4
  - CASP5
  - CASP6
  - CASP8
  - CASP9
  - CASP10
  - CASP12
  - CASP14
  - CASP3
  - CASP7
  - CAPN2
  - MYC
  - RPL29
  - RPN2
  - PSMD1
  - HSPB1
  - HSPB2
  - PCGF2
  - TRIP12
  - PHLDA1
  - SRPK2
  - IMPACT
  - TRMT1L
  - CEPT1
  - PHB2
  - MGST3
  - MYOC
  - PTMA
  - PTMAP4
  - Tmem126a
  - Sin3b
  - Lsm3
  - Xrn2
  - Lsm1
  - Ptprcap
  - Ctnna1
  - Tyms
  - Cast
  - Polr1g
  - Erc2
  - Fanci
  - Uxt
  - Top1
  - Hps3
  - Ncbp1
  - Hnrnph1
  - Anxa4
  - Capn2
  - Myc
  - Nol3
  - Rpl29
  - Gm8210
  - Rpn2
  - Casp9
  - Hspb2
  - Pcgf2
  - Trip12
  - Phlda1
  - Casp2
  - Srpk2
  - Impact
  - Trmt1l
  - Cept1
  - Phb2
  - Mgst3
  - Myoc
  - Ptma
  - Erc1
  - Hspb1
---
